Literature DB >> 17436568

Review. Acridine orange could be an innovative anticancer agent under photon energy.

Katsuyuki Kusuzaki1, Hiroaki Murata, Takao Matsubara, Haruhiko Satonaka, Toru Wakabayashi, Akihiko Matsumine, Atsumasa Uchida.   

Abstract

Acridine orange (AO) was extracted as a dye from coal tar over a hundred years ago. It has various unique biological activities and has been shown to be a useful fluorescent dye specific for DNA and RNA, a pH indicator, photosensitizer, antitumor and antimalarial drug, and detector of bacteria and parasites. It has recently been found that AO accumulates in musculoskeletal sarcomas and that after illumination of the tumors with visible light or irradiation with low-dose X-rays, the dye rapidly exerts selective cytocidal effect against the sarcoma cells. Therefore, surgery combined with photo- (PDT) or radiodynamic therapy (RDT) with AO (AO-PDT and -RDT) has been applied to human musculoskeletal sarcomas. The results of a clinical study on the outcome of this therapeutic strategy revealed that it yielded better local control and remarkably better limb function than wide resectional surgery. Based on our experimental studies, it was clarified that AO accumulates in acidic organelles or structures, especially lysosomes, depending on the acidity. An enormous number of protons are produced in cancer from lactate or CO2 under hypoxic conditions, which are moved into the extracellular fluid or lysosomes to maintain the intracellularfluid pH. Therefore, AO shows marked accumulation in the acidic lysosomes of cancer cells. Photon energy from visible light or X-rays excites the AO accumulated in lysosomes; the excited AO emits fluorescence and forms activated oxygen from intra-cytoplasmic oxygen. The activated oxygen destroys lysosomes, with the released lysosomal enzymes causing rapid death of the cancer cells. On the other hand, normal cells can exclude AO quickly because they are not acidic. Thus, AO-PDT and AO-RDT exhibit strong and selective cytocidal effect against malignant tumors. In conclusion, we believe that AO-PDT and AO-RDT exhibit selective anticancer cell activity and that AO excited by photon energy has excellent potential as an anticancer agent.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17436568

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  19 in total

Review 1.  Optical and x-ray technology synergies enabling diagnostic and therapeutic applications in medicine.

Authors:  Brian W Pogue; Brian C Wilson
Journal:  J Biomed Opt       Date:  2018-10       Impact factor: 3.170

2.  In vivo anti-tumor activity of photodynamic therapy with intravenous administration of acridine orange, followed by illumination with high-power flash wave light in a mouse osteosarcoma model.

Authors:  Haruhiko Satonaka; Katsuyuki Kusuzaki; Takao Matsubara; Ken Shintani; Tomoki Nakamura; Akihiko Matsumine; Takahiro Iino; Atsumasa Uchida
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

3.  Can a less radical surgery using photodynamic therapy with acridine orange be equal to a wide-margin resection?

Authors:  Takao Matsubara; Katsuyuki Kusuzaki; Akihiko Matsumine; Tomoki Nakamura; Akihiro Sudo
Journal:  Clin Orthop Relat Res       Date:  2013-03       Impact factor: 4.176

4.  Intraoperative acridine orange photodynamic therapy and cribriform electron-beam irradiation for canine intranasal tumors: A pilot study.

Authors:  Takuya Maruo; Koichi Nagata; Yasuhiro Fukuyama; Yuki Nemoto; Shinpei Kawarai; Yukihiro Fujita; Tomohiro Nakayama
Journal:  Can Vet J       Date:  2015-12       Impact factor: 1.008

5.  Glucosamine-bound near-infrared fluorescent probes with lysosomal specificity for breast tumor imaging.

Authors:  Cong Li; Tiffany R Greenwood; Kristine Glunde
Journal:  Neoplasia       Date:  2008-04       Impact factor: 5.715

6.  A mini-review of X-ray photodynamic therapy (XPDT) nonoagent constituents' safety and relevant design considerations.

Authors:  A Belanova; V Chmykhalo; D Beseda; M Belousova; V Butova; A Soldatov; Y Makarenko; P Zolotukhin
Journal:  Photochem Photobiol Sci       Date:  2020-09-09       Impact factor: 3.982

7.  Excimer Emission of Acridine Orange Adsorbed on Gadolinium-Yttrium Orthovanadate Nanoparticles.

Authors:  K O Hubenko; S L Yefimova; T N Tkacheva; P O Maksimchuk; O O Sedyh; O G Viagin; A V Sorokin; Yu V Malyukin
Journal:  J Fluoresc       Date:  2018-06-30       Impact factor: 2.217

8.  Intraoperative acridine orange photodynamic therapy and cribriform electron-beam irradiation for canine intranasal carcinomas: 14 cases.

Authors:  Takuya Maruo; Yasuhiro Fukuyama; Koichi Nagata; Chie Yoshioka; Yuta Nishiyama; Shinpei Kawarai; Hideki Kayanuma; Kensuke Orito; Tomohiro Nakayama
Journal:  Can Vet J       Date:  2019-05       Impact factor: 1.008

9.  Recurrence analysis of intraoperative acridine orange-photodynamic therapy for dogs with intranasal tumors.

Authors:  Takuya Maruo; Yasuhiro Fukuyama; Yuta Nishiyama; Yuki Nemoto; Eiichi Kanai; Shinpei Kawarai; Hideki Kayanuma; Kensuke Orito
Journal:  Can Vet J       Date:  2021-10       Impact factor: 1.008

10.  Lansoprazole as a rescue agent in chemoresistant tumors: a phase I/II study in companion animals with spontaneously occurring tumors.

Authors:  Enrico P Spugnini; Alfonso Baldi; Sabrina Buglioni; Francesca Carocci; Giulia Milesi de Bazzichini; Gianluca Betti; Ilaria Pantaleo; Francesco Menicagli; Gennaro Citro; Stefano Fais
Journal:  J Transl Med       Date:  2011-12-28       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.